• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化患者在反复进行 24 小时呼吸描记术时的咳嗽和呼吸模式的新见解。

Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies.

机构信息

Department of Pulmonary Medicine, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse, 3010, Bern, Switzerland.

出版信息

Respir Res. 2017 Nov 13;18(1):190. doi: 10.1186/s12931-017-0674-y.

DOI:10.1186/s12931-017-0674-y
PMID:29132424
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5683431/
Abstract

BACKGROUND

The main symptoms of patients with idiopathic pulmonary fibrosis (IPF) are cough and dyspnea. IPF leads to a restrictive lung disorder impacting daytime and nocturnal breathing patterns. In this pilot study we assessed the course of day- and nighttime respiration, oxygenation, and cough over a period of 8 months as well as differences between wakefulness and sleep in IPF patients.

METHODS

Repetitive 24-h respiratory polygraphies (RP) and pulmonary function tests were performed at baseline and after 3, 4, 7 and 8 months. Cough-index, oxygenation parameters (SpO2, time with SpO2 < 90%, desaturation index), respiratory rate and heart rate were assessed for differences between wakefulness and sleep. The first and the last RP were compared to identify changes of these parameters over time. Statistical analyses were performed with Wilcoxon signed rank tests.

RESULTS

Nine IPF patients (8 male, median age 67 years (IQR 60, 77) with 37 valid 24-h RPs were included. Eight patients (88.9%) received antifibrotic treatment. Cough was more prevalent during wakefulness with a median cough-index of 14.8/h (IQR 10.9, 16.8) and 1.6/h (IQR 1.3-2.8) during sleep, p = 0.0039. Oxygenation parameters showed no difference, while respiratory- and heart rate were significantly higher during wakefulness. Despite stable pulmonary function tests over 8 months, the initially elevated respiratory rate increased further during wakefulness (baseline RR median 25.7/min (IQR 19.8, 26.6) vs. RR median 32.2/min (IQR 26.5, 40.9) at follow-up, p = 0.0273). The other respiratory parameters remained stable over time.

CONCLUSION

Cough in IPF patients is more prevalent during wakefulness than during sleep. Further studies with a larger sample size and longer a follow-up period are needed to evaluate the role of the respiratory rate during wakefulness as a potential clinical follow up parameter in IPF.

摘要

背景

特发性肺纤维化(IPF)患者的主要症状是咳嗽和呼吸困难。IPF 导致限制性肺疾病,影响白天和夜间的呼吸模式。在这项初步研究中,我们评估了 8 个月期间白天和夜间呼吸、氧合和咳嗽的过程,以及 IPF 患者在清醒和睡眠之间的差异。

方法

在基线时以及在 3、4、7 和 8 个月后进行重复 24 小时呼吸描记术(RP)和肺功能检查。评估咳嗽指数、氧合参数(SpO2、SpO2<90%的时间、脱氧指数)、呼吸频率和心率在清醒和睡眠之间的差异。比较第一个和最后一个 RP,以确定这些参数随时间的变化。使用 Wilcoxon 符号秩检验进行统计分析。

结果

纳入了 9 名 IPF 患者(8 名男性,中位年龄 67 岁(IQR 60,77),37 份有效 24 小时 RP)。8 名患者(88.9%)接受了抗纤维化治疗。咳嗽在清醒时更为常见,中位咳嗽指数为 14.8/h(IQR 10.9,16.8),睡眠时为 1.6/h(IQR 1.3-2.8),p=0.0039。氧合参数无差异,而呼吸和心率在清醒时明显较高。尽管 8 个月后肺功能检查稳定,但最初升高的呼吸率在清醒时进一步升高(基线 RR 中位数 25.7/min(IQR 19.8,26.6)与随访时 RR 中位数 32.2/min(IQR 26.5,40.9),p=0.0273)。其他呼吸参数随时间保持稳定。

结论

与睡眠时相比,IPF 患者的咳嗽在清醒时更为常见。需要进一步的研究,包括更大的样本量和更长的随访时间,以评估清醒时呼吸率作为 IPF 潜在临床随访参数的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/196a/5683431/4907a2262261/12931_2017_674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/196a/5683431/4907a2262261/12931_2017_674_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/196a/5683431/4907a2262261/12931_2017_674_Fig1_HTML.jpg

相似文献

1
Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies.特发性肺纤维化患者在反复进行 24 小时呼吸描记术时的咳嗽和呼吸模式的新见解。
Respir Res. 2017 Nov 13;18(1):190. doi: 10.1186/s12931-017-0674-y.
2
Sleep and breathing in idiopathic pulmonary fibrosis.特发性肺纤维化中的睡眠和呼吸。
J Physiol Pharmacol. 2009 Nov;60 Suppl 5:13-4.
3
A novel formulation of inhaled sodium cromoglicate (PA101) in idiopathic pulmonary fibrosis and chronic cough: a randomised, double-blind, proof-of-concept, phase 2 trial.吸入性色甘酸钠(PA101)治疗特发性肺纤维化和慢性咳嗽的新配方:一项随机、双盲、概念验证、2 期临床试验。
Lancet Respir Med. 2017 Oct;5(10):806-815. doi: 10.1016/S2213-2600(17)30310-7. Epub 2017 Sep 8.
4
Health-Related Quality of Life in Patients with Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者的健康相关生活质量
Lung. 2016 Apr;194(2):227-34. doi: 10.1007/s00408-016-9850-y. Epub 2016 Feb 9.
5
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.特发性肺纤维化患者的睡眠氧减预测生存。
J Clin Sleep Med. 2013 Jun 15;9(6):593-601. doi: 10.5664/jcsm.2758.
6
Evaluation of a respiratory symptom diary for clinical studies of idiopathic pulmonary fibrosis.特发性肺纤维化临床研究中呼吸症状日记的评估。
Respir Med. 2018 Jan;134:130-138. doi: 10.1016/j.rmed.2017.11.011. Epub 2017 Nov 26.
7
Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.放射性肺气肿对特发性肺纤维化肺功能检查的影响。
Respir Med. 2013 Nov;107(11):1781-8. doi: 10.1016/j.rmed.2013.08.039. Epub 2013 Sep 3.
8
Breathing pattern and breathlessness in idiopathic pulmonary fibrosis: An observational study.特发性肺纤维化患者的呼吸模式和呼吸困难:一项观察性研究。
Respirology. 2016 Feb;21(2):344-9. doi: 10.1111/resp.12686. Epub 2015 Nov 24.
9
Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.用于识别硬化性肺病或特发性肺纤维化中的间质性肺病并预测肺功能下降的生物标志物。
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Sep 14;32(3):228-36.
10
Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.血管生成素-1和-2对特发性肺纤维化临床病程的影响。
Respir Med. 2016 May;114:18-26. doi: 10.1016/j.rmed.2016.03.001. Epub 2016 Mar 5.

引用本文的文献

1
Updates on the Prevalence, Quality of Life, and Management of Chronic Cough in Interstitial Lung Diseases.间质性肺疾病中慢性咳嗽的患病率、生活质量及管理的最新进展
Diagnostics (Basel). 2025 Apr 29;15(9):1139. doi: 10.3390/diagnostics15091139.
2
Assessment and Management of Cough in Idiopathic Pulmonary Fibrosis: A Narrative Review.特发性肺纤维化中咳嗽的评估与管理:一项叙述性综述
Lung. 2023 Dec;201(6):531-544. doi: 10.1007/s00408-023-00653-3. Epub 2023 Nov 7.
3
Characteristics of idiopathic pulmonary fibrosis -associated cough. a case-control study.

本文引用的文献

1
Improving Survival in Idiopathic Pulmonary Fibrosis: The Race Has Just Begun.提高特发性肺纤维化的生存率:征程才刚刚开始。
Chest. 2017 Mar;151(3):527-528. doi: 10.1016/j.chest.2017.01.007.
2
Cough in idiopathic pulmonary fibrosis.特发性肺纤维化中的咳嗽
Eur Respir Rev. 2016 Sep;25(141):278-86. doi: 10.1183/16000617.0090-2015.
3
Breathing pattern and breathlessness in idiopathic pulmonary fibrosis: An observational study.特发性肺纤维化患者的呼吸模式和呼吸困难:一项观察性研究。
特发性肺纤维化相关咳嗽的特征。一项病例对照研究。
BMC Pulm Med. 2023 May 23;23(1):179. doi: 10.1186/s12890-023-02476-7.
4
The Association between Idiopathic Pulmonary Fibrosis and Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.特发性肺纤维化与阻塞性睡眠呼吸暂停之间的关联:一项系统评价与荟萃分析
J Clin Med. 2022 Aug 26;11(17):5008. doi: 10.3390/jcm11175008.
5
Predicting Adverse Events During Six-Minute Walk Test Using Continuous Physiological Signals.使用连续生理信号预测六分钟步行试验期间的不良事件
Front Physiol. 2022 Jun 6;13:887954. doi: 10.3389/fphys.2022.887954. eCollection 2022.
6
Clinical significance of pectoralis muscle strength in elderly patients with idiopathic pulmonary fibrosis.特发性肺纤维化老年患者胸肌力量的临床意义
Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(1):e2022009. doi: 10.36141/svdld.v39i1.12094. Epub 2022 Mar 31.
7
Evaluation of respiratory rate monitoring performance using a home oxygen monitoring device among patients with interstitial lung disease and chronic obstructive pulmonary disease.使用家用氧气监测设备对间质性肺疾病和慢性阻塞性肺疾病患者的呼吸频率监测性能进行评估。
Sarcoidosis Vasc Diffuse Lung Dis. 2022;39(1):e2022007. doi: 10.36141/svdld.v39i1.12133. Epub 2022 Mar 31.
Respirology. 2016 Feb;21(2):344-9. doi: 10.1111/resp.12686. Epub 2015 Nov 24.
4
Idiopathic pulmonary fibrosis: Diagnosis, epidemiology and natural history.特发性肺纤维化:诊断、流行病学及自然史
Respirology. 2016 Apr;21(3):427-37. doi: 10.1111/resp.12683. Epub 2015 Nov 23.
5
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会特发性肺纤维化临床实践指南:治疗。对 2011 年临床实践指南的更新。
Am J Respir Crit Care Med. 2015 Jul 15;192(2):e3-19. doi: 10.1164/rccm.201506-1063ST.
6
The prognostic significance of respiratory rate in patients with pneumonia: a retrospective analysis of data from 705,928 hospitalized patients in Germany from 2010-2012.呼吸率对肺炎患者预后的意义:2010-2012 年德国 705928 例住院患者数据的回顾性分析。
Dtsch Arztebl Int. 2014 Jul 21;111(29-30):503-8, i-v. doi: 10.3238/arztebl.2014.0503.
7
Sleep oxygen desaturation predicts survival in idiopathic pulmonary fibrosis.特发性肺纤维化患者的睡眠氧减预测生存。
J Clin Sleep Med. 2013 Jun 15;9(6):593-601. doi: 10.5664/jcsm.2758.
8
Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine.睡眠呼吸事件的评分规则:2007 年美国睡眠医学学会睡眠和相关事件评分手册的更新。美国睡眠医学学会睡眠呼吸暂停定义工作组的审议。
J Clin Sleep Med. 2012 Oct 15;8(5):597-619. doi: 10.5664/jcsm.2172.
9
Monitoring breathing rate at home allows early identification of COPD exacerbations.在家监测呼吸频率可早期识别 COPD 加重。
Chest. 2012 Dec;142(6):1524-1529. doi: 10.1378/chest.11-2728.
10
A multidimensional index and staging system for idiopathic pulmonary fibrosis.特发性肺纤维化的多维指数和分期系统。
Ann Intern Med. 2012 May 15;156(10):684-91. doi: 10.7326/0003-4819-156-10-201205150-00004.